Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ETHZilla Corp Director's Dealing 2025

Feb 25, 2025

33039_dirs_2025-02-24_4bc9dd62-748c-4ec5-b59d-91b488ebea90.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: 180 Life Sciences Corp. (ATNF)
CIK: 0001690080
Period of Report: 2025-02-15

Reporting Person: Van Lent Eric R (Chief Accounting Officer)